Nuclear survivin as a biomarker for non-small-cell lung cancer

被引：0
|
作者：
B Lu
A Gonzalez
P P Massion
Y Shyr
B Shaktour
D P Carbone
D E Hallahan
机构：
[1] Vanderbilt Ingram,Department of Radiation Oncology
[2] Cancer Center,Department of Pathology
[3] Vanderbilt University School of Medicine,Department of Medicine
[4] Vanderbilt Ingram,Department of Preventive Medicine
[5] Cancer Center,undefined
[6] Vanderbilt University School of Medicine,undefined
[7] Vanderbilt Ingram,undefined
[8] Cancer Center,undefined
[9] Vanderbilt University School of Medicine,undefined
[10] Vanderbilt Ingram,undefined
[11] Cancer Center,undefined
[12] Vanderbilt University School of Medicine,undefined
来源：
British Journal of Cancer | 2004年 / 91卷
关键词：
survivin; lung cancer; nucleus; tissue array; mitosis; apoptosis;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Survivin inhibits apoptosis and promotes mitosis. We determined whether nuclear or cytoplasmic localisation of survivin predicts survival of 48 patients with resected non-small-cell lung cancer (NSCLC). Patients with nuclear staining of survivin had significantly worse survival (relative risk: 3.9, P=0.02). Therefore, survivin may be a biomarker for NSCLC.
引用
收藏
页码：537 / 540
页数：3
相关论文
共 50 条
  • [31] CD133 and non-small-cell lung cancer
    Wiwanitkit, Viroj
    EUROPEAN JOURNAL OF CARDIO-THORACIC SURGERY, 2010, 37 (04) : 988 - 988
  • [32] Effect of Smac and Taxol on non-small-cell lung cancer
    Peng, Chuanliang
    Hao, Yingtao
    Zhao, Yunpeng
    Sun, Qifeng
    Zhao, Xiaogang
    Cong, Bo
    ACTA BIOCHIMICA ET BIOPHYSICA SINICA, 2014, 46 (05) : 387 - 393
  • [33] Gemcitabine: A reality in the treatment of non-small-cell lung cancer
    Rinaldi, M
    TUMORI, 1997, 83 (06) : S3 - S7
  • [34] Anthropometric measurements in non-small-cell lung cancer - Reply
    Ferrigno, D
    SUPPORTIVE CARE IN CANCER, 2002, 10 (05) : 440 - 440
  • [35] New TNM classification for non-small-cell lung cancer
    Tanoue, Lynn T.
    Detterbeck, Frank C.
    EXPERT REVIEW OF ANTICANCER THERAPY, 2009, 9 (04) : 413 - 423
  • [36] Clusterin modulates transdifferentiation of non-small-cell lung cancer
    Runsen Jin
    Xingshi Chen
    Dingpei Han
    Xiaoying Luo
    Hecheng Li
    BMC Cancer, 17
  • [37] EGFR mutation analysis in non-small-cell lung cancer
    Tapia, C.
    Savic, S.
    Bihl, M.
    Rufle, A.
    Zlobec, I.
    Terracciano, L.
    Bubendorf, L.
    PATHOLOGE, 2009, 30 (05): : 384 - 392
  • [38] Italian clinical research in non-small-cell lung cancer
    Gridelli, Cesare
    Rossi, A.
    Galetta, D.
    Maione, P.
    Ferrara, C.
    Guerriero, C.
    Del Gaizo, F.
    Nicolella, D.
    Colantuoni, G.
    Gebbia, V.
    Colucci, G.
    ANNALS OF ONCOLOGY, 2005, 16 : 110 - 115
  • [39] Current surgical treatment of non-small-cell lung cancer
    Van Schil, Paul E.
    Hendriks, Jeroen M.
    Hertoghs, Marjan
    Lauwers, Patrick
    Choong, Cliff
    EXPERT REVIEW OF ANTICANCER THERAPY, 2011, 11 (10) : 1577 - 1585
  • [40] Concomitant radiochemotherapy of advanced non-small-cell lung cancer
    Fietkau, R
    LUNG CANCER, 2001, 33 : S65 - S76
12345